24.08.2014 18:52:38
|
Roche To Buy InterMune For $8.3 Bln
(RTTNews) - Swiss pharmaceutical giant Roche Holding AG (RHHBY.PK, ROG.SW, RO.SW) Sunday said it agreed to buy US biotech company InterMune Inc. (ITMN) for $8.3 billion in cash.
Roche will pay InterMune shareholders $74.00 a share in cash, representing a premium of 38 percent to InterMune's closing price on Friday, August 22. The merger agreement has been approved by the boards of InterMune and Roche.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu InterMune Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |